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The development of biotechnology industry is strongly
based on the interaction with research laboratories and
universities. The process of creating new companies and
bringing new products to the market depend on how
the actors are prepared and aware about the innovation
process. Successful movements towards acceleration
startups have overcome two major difficulties: Dissemi-
nation of the innovation virus in the academy and get
enough critical mass of brain and resources. How long
does it take to change the order of magnitude of the
production of a new material from milligrams to tons?
A PhD student probably has speculated about the final
use of the new biomaterial introduced subcutaneously in
some (un)fortunate mice. It is important to make
researchers aware that one does not need to leave the
comfort zone and face risks in a jungle to think big and
find a noble application for their pet biomaterial. It is
known that creative energy may be used beyond the
Petri’s dishes, bioreactors, scientific papers and patent
applications. The ideas, like stem cells, may differentiate
in whatever product the scientist mind would imagine.
To play the game of innovation, scientists must learn
new rules and new metrics. To be successful in this
race, one must work hard and have a strategy. Probably,
the podium will not be achieved in the first race but the
sweat drops will evaporate from the road as quickly as
the entrepreneur is getting better. He/she will evolve. So
as patents and papers will evolve to business plan, in
vitro/in vivo test will evolve to clinical trials or to medical
prescriptions and inventions will transform into innova-
tions. In order to survive in the 21st Century environment,
the new species of entrepreneur with PhD degree, Homo
innovatus, will populate biotechnology startups. In more
evolved ecosystems, ideas and knowledge are translated
into innovation. The process becomes easier when there is
a minimum of critical mass of people and companies. The
combination of quality, diversity and large number of ideas
makes huge difference in a cluster. The main challenge is
how to concentrate bright people in one place. There are a
number of strategies to make it happen. The process of
attracting talents to a region is to provide infrastructure for
good life quality, i.e., high quality elementary and second-
ary schools for the children, nice hospitals, variety of cul-
tural and touristic attractions. It is also necessary to create
a flow of bright people into the place. The best way of
achieving this is to have a number of universities that pro-
vide high quality workforce for the companies. The reputa-
tion of good salaries, good place to raise the family, good
cultural activities help immensely to create and strengthen
the brand of the cluster. Other than traditional metrics, the
impact of cluster on the local and regional economic devel-
opment and quality of life will be decisive on the success of
attraction of talents and investments to a city or region.
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